Skip to main content
. 2010 Jul;35(4):229–236. doi: 10.1503/jpn.090051

Table 1.

Demographic and clinical characteristics of participants

Group; mean (SD)*
Characteristic Schizophrenia, n = 12 Mood disorder, n = 12 Healthy control, n = 17
Age, yr, mean (SD) [range] 16.2 (2.5) [12.1–19.7] 14.9 (1.9) [12.9–17.9] 15.9 (2.1) [12.1–19.1]
Head circumference, mm 561.0 (14.8) 531.5 (15.6) 555.5 (27.2)
Intracranial volume, mm3 1341.8 (108.6) 1235.7 (142.1) 1365.7 (167.4)
Male, no. (%) of participants 9 (75) 4 (33) 10 (59)
Nonwhite, no. (%) of participants 6 (50) 3 (25) 8 (47)
Age at onset, yr 13.55 (4.27) 12.83 (2.79)
Duration of illness, yr 2.60 (2.67) 2.03 (1.81)
Previous hospitalizations, no. 1.09 (1.58) 0.50 (0.67)
Medication history, no. (%) of participants
 Previous typical antipsychotic 7 (58) 0
 Previous risperidone 8 (67) 4 (33)
 Previous olanzapine 6 (50) 3 (25)
 Previous other atypical antipsychotic 0 1 (8)
 Previous antidepressant medications 6 (50) 6 (50)
 Previous mood stabilizer 2 (17) 1 (8)
Symptom severity
 Childhood psychiatric rating scale, positive symptoms 29.45 (1.37) 31.42 (6.44)
 Childhood psychiatric rating scale, negative symptoms 24.18 (14.53) 19.08 (12.72)
 Brief psychiatric rating for children, total score 73.2 (14.7) 74.7 (11.6)
 Depression items 9.3 (4.9) 12.7 (4.4)
 Mania items 12.1 (4.3) 14.0 (4.0)
 Baseline intelligence quotient 79.1 (14.9) 98.2 (12.8)

SD = standard deviation.

*

Unless otherwise indicated.